Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study
Version 2 2024-06-02, 23:22Version 2 2024-06-02, 23:22
Version 1 2023-11-02, 05:12Version 1 2023-11-02, 05:12
journal contribution
posted on 2024-06-02, 23:22authored byHM Prince, MJ Millward, D Rischin, D Blakey, P Francis, Priscilla GatesPriscilla Gates, P Chapple, M Quinn, S Juneja, M Wolf, EH Januszewicz, JF Seymour, M Brettell, A Strickland, J Zalcberg, G Richardson, J Scarlett, P Briggs, GC Toner
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study